Literature DB >> 1997469

Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.

A Bosse1, Y Ueda, P Wuisman, D B Jones, E Vollmer, A Roessner.   

Abstract

The histogenesis of clear cell chondrosarcoma is still unclear: Apart from typical clear cell tumor areas, extensive production of woven bone formation suggests within the clear cell cartilagenous stroma is an intriguing phenomenon. Three cases of clear cell chondrosarcoma documented in the Bone Tumor Registry of Westphalia were examined for their patterns of osteonectin expression, and compared with other bone tumors of either osseous or cartilaginous origin, and with normal cartilage tissue. Found predominantly in osseous structures, the protein osteonectin takes part in the formation of new bone. The three clear cell chondrosarcomas showed a strong immunoexpression of osteonectin in clear cell, chondroid and in osseous tumor areas. Similarly, evidence of osteonectin was also found in osteoblastic and in chondroblastic osteosarcomas as well as in osteoblastomas. In contrast, osteonectin could not be demonstrated in the chondrosarcomas and mesenchymal chondrosarcomas from our registry that were analysed for comparison, and was found only minimally in the fibroblastic areas of dedifferentiated chondrosarcomas. The chondroblastic tumor components were always negative. There was no immunoexpression of osteonectin either in fetal or adult intervertebral disc tissue. The present immunohistochemical study of osteonectin has distinctly separated clear cell chondrosarcoma from the other variants of chondrosarcoma, and aptly verified the specificity of this entity. Moreover, the study would call for further histogenetic evaluation of clear cell chondrosarcoma, since the pattern of osteonectin expression in that tumor seems to indicate an osteogenic rather than a chondrogenic origin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1997469     DOI: 10.1007/bf01613195

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  Chondrosarcoma: clear-cell variant. A report of sixteen cases.

Authors:  K K Unni; D C Dahlin; J W Beabout; F H Sim
Journal:  J Bone Joint Surg Am       Date:  1976-07       Impact factor: 5.284

2.  Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats.

Authors:  C Maniatopoulos; J Sodek; A H Melcher
Journal:  Cell Tissue Res       Date:  1988-11       Impact factor: 5.249

3.  Clear-cell chondrosarcoma. A light- and electron-microscopic and histochemical study of two cases.

Authors:  L Angervall; L G Kindblom
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

4.  Separation of bone matrix proteins by calcium-induced precipitation.

Authors:  Y Kuboki; H Takita; T Komori; M Mizuno; E Furu-uchi; K Taniguchi
Journal:  Calcif Tissue Int       Date:  1989-04       Impact factor: 4.333

5.  Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone.

Authors:  Y Ueda; Y Oda; H Tsuchiya; K Tomita; I Nakanishi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  Tumor cell types in osteosarcoma as revealed by electron microscopy. Implications for histogenesis and subclassification.

Authors:  E Grundmann; A Roessner; M Immenkamp
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1981

7.  Osteonectin--a differentiation marker of bone cells.

Authors:  G Jundt; K H Berghäuser; J D Termine; A Schulz
Journal:  Cell Tissue Res       Date:  1987-05       Impact factor: 5.249

8.  Characterization of porcine osteonectin extracted from foetal calvariae.

Authors:  C Domenicucci; H A Goldberg; T Hofmann; D Isenman; S Wasi; J Sodek
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

9.  Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid).

Authors:  M E Bolander; M F Young; L W Fisher; Y Yamada; J D Termine
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  Expression of SPARC/osteonectin transcript in murine embryos and gonads.

Authors:  C C Howe; G C Overton; J Sawicki; D Solter; P Stein; S Strickland
Journal:  Differentiation       Date:  1988       Impact factor: 3.880

View more
  1 in total

1.  Clear cell chondrosarcoma is an underestimated tumor: Report of 7 cases and meta-analysis of the literature.

Authors:  Alexander Klein; Felix Tauscher; Christof Birkenmaier; Andrea Baur-Melnyk; Thomas Knösel; Volkmar Jansson; Hans Roland Dürr
Journal:  J Bone Oncol       Date:  2019-10-31       Impact factor: 4.072

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.